Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model
Topical RCI001 demonstrated excellent therapeutic efficacy in a mouse model of primary Sjögren syndrome by inhibiting inflammation and oxidative stress.
Authors
- Youngho Jung (ORCID: https://orcid.org/0000-0002-8754-3301)
- Chang Ho Yoon (ORCID: https://orcid.org/0000-0003-2203-5709)
- Mee Kum Kim (ORCID: https://orcid.org/0000-0001-7850-6894)
- Dong Hyun Kim (ORCID: https://orcid.org/0000-0002-3985-990X)
- Yong Ho Kim (ORCID: https://orcid.org/0000-0001-8704-3553)
- Jayoon Moon (ORCID: https://orcid.org/0000-0002-2833-3785)
- Jin Suk Ryu
- Hyereen Kang
Institutions
- Gachon University (KR)
- Seoul National University (KR)
- Korea University (KR)
- Seoul National University Hospital (KR)
- Nune Eye Hospital (KR)
Publication Details
- Journal
- Cornea
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1097/ico.0000000000003696
- Citations
- 1
- Primary Topic
- Ocular Surface and Contact Lens
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- National Research Foundation
- Korea University
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Korea University Anam Hospital